Connected Drug Delivery Device

SITUATION

A major pharmaceutical manufacturer made a strategic decision to move “beyond the pill” but had no internal experience with devices and apps.  They turned to Syncro Medical to design and implement their initial combination product offering, consisting of companion apps for a new family of connected drug delivery devices.

APPROACH

To help their R&D team secure management approval, Syncro first created prototypes for wireless device/app communications, UI and workflow.

Because cross platforms were not mature enough for the hardware interaction need when the program initiated, client requested that the first version be native implementation – Swift for iOS, Kotlin for Android. (For a second-generation product, Syncro Medical developed a new app using Dart/Flutter.)  The app receives usage information from the BLE-enabled drug delivery device and provides real-time feedback to the patient on drug delivery quality and potential overuse, plus supports a myriad of additional features for physician and patient support and disease management. The data is pushed to the cloud backend for sharing with physicians and other caregivers.

OUTCOME

With Syncro Medical’s help, this client was the first-to-market with an FDA-approved connected drug delivery system for asthma patients, confirming this client’s status as a leader in the segment.  Syncro Medical is now working on companion apps for this client’s other medication delivery systems.